Cancer Genetics

^{Priced, OTC: CGIX}

Offers personalized genomic tests to improve the diagnosis and treatment of cancer.

Industry: Health Care

First Day Return: +12.5%

CGIX

Offers personalized genomic tests to improve the diagnosis and treatment of cancer.

IPO News for Cancer Genetics

US IPO Weekly Recap: Seven deals price, six new filers 03/25/13
Cancer Genetics postpones $18 million IPO 03/19/13
9 US IPOs planned for the week of Mar 18 03/18/13

IPO Data
IPO Date	04/04/2013
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$6
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.cancergenetics.com
Headquarters	Rutherford, NJ, United States
Founded	1999
Employees at IPO	47

IPO News for Cancer Genetics

US IPO Weekly Recap: Seven deals price, six new filers 03/25/13
Cancer Genetics postpones $18 million IPO 03/19/13
9 US IPOs planned for the week of Mar 18 03/18/13

Cancer Genetics (CGIX) Performance